A year later, in 2001, the first transgenic pigs from genetically engineered donor cells were reported thus demonstrating that donor cells could undergo the process of genetic modification and still be clonable. Through this alteration of the genome and subsequent SCNT,the idea of using GE pigs as human biomedical models was advanced.